Skip to main navigation
Skip to search
Skip to main content
Research Profiles at Washington University School of Medicine Home
Help & FAQ
Home
Profiles
Departments, Divisions and Centers
Research output
Search by expertise, name or affiliation
Treatment of aggressive histology lymphoma
Nancy L. Bartlett
Siteman Cancer Center
Section of Medical Oncology
Research output
:
Contribution to journal
›
Review article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Treatment of aggressive histology lymphoma'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Lymphoma
100%
Aggressive Lymphoma
100%
Aggressive Histology
100%
High Risk
50%
Prognostic Factors
50%
High Dose
25%
Poor Prognosis
25%
Clinical High Risk
25%
Primary Therapy
25%
Complete Remission
25%
Bone Marrow Transplantation
25%
New Regimen
25%
Autologous Peripheral Blood Stem Cells
25%
Hematopoietic Growth Factors
25%
Third Generation
25%
Rapid Succession
25%
Factor Index
25%
High-dose Cytarabine
25%
Growth Factor Support
25%
Cell Lymphoma
25%
Dose-intense
25%
Medicine and Dentistry
Aggressive Lymphoma
100%
Drug Megadose
50%
Prognostic Factor
50%
Cytarabine
25%
Growth Factor
25%
Bone Marrow Transplantation
25%
Peripheral Blood Stem Cell
25%
Hemopoietic Growth Factor
25%
Undifferentiated Lymphoma
25%